MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
BBLG - Bone Biologics Corp
$4.05
-0.04(-0.98%)6:00:00 PM 11/26/2021
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra
leak data

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

leak data

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

No summary
Related Topics
Peers

Related Peers

Stock news

    11/17/2021BBLG
    25 Stocks Moving in Wednesday's Pre-Market Session

    Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10 million buyback program. Rockwell Medical, Inc. (NASDAQ: RMTI) rose 58.6% to $0.7632 in pre-market trading after the company announced results from a study demonstrated no drug-drug interaction between ferric pyrophosphate citrate and unfractionated heparin. SPI Energy Co., Ltd. (NASDAQ: SPI) shares rose 20% to $7.38 in pre-mark

    11/16/2021BBLG
    36 Stocks Moving in Tuesday's Pre-Market Session

    Gainers BIMI International Medical Inc. (NASDAQ: BIMI) rose 63.9% to $1.07 in pre-market trading as the company reported a narrower Q3 loss. Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 58.2% to $13.30 in pre-market trading following a positive clinical readout. Kezar announced positive interim results from the Phase 2 portion of the MISSION clinical study evaluating KZR-616 in patients with lupus nephritis.. Creatd, Inc. (NASDAQ: CRTD) shares rose 24% to $3.88 in pre-market trading after report

    11/10/2021BBLG
    BBLG: Bone Biologics

    By Brad Sorensen, CFA NASDAQ:BBLG 65 million Americans reported a recent case of back pain in the past year, while 16 million have what would be considered chronic back pain. According to the Georgetown Health Policy Institute, health care costs and indirect costs due to back pain are more than $12 billion per year. No doubt a big problem, and that’s just in the US, but what is being done about

    11/2/2021BBLG
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

    Good morning, trader! We’re getting right into the thick of it today with a look at the biggest pre-market stock movers for Tuesday. Source: f11photo/Shutterstock.com We’ve got earnings reports, analyst coverage, and more to examine as shares move this morning. Let’s dive into those pre-market stock movers below!InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-Market Stock Movers: 10 Top Gainers Baosheng Media Group (NASDAQ:BAOS) stock is rocketing more than 97% as retail trade

    11/2/2021BBLG
    24 Stocks Moving in Tuesday's Pre-Market Session

    Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) rose 119% to $3.43 in pre-market trading after declining 3% on Monday. The company, last month, swung to a loss in the first half of the year. Bone Biologics Corporation (NASDAQ: BBLG) rose 61.8% to $8.86 in pre-market trading. An amended 13D filing on Monday from Hankey Capital, LLC showed a 69% stake in the company. Nxt-ID, Inc. (NASDAQ: NXTD) shares rose 44.1% to $6.37 in pre-market trading after jumping 19% on Monday. SAB Biotherap

    10/18/2021BBLG
    Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq

    BURLINGTON, Mass., October 18, 2021--Bone Biologics Corp. (NASDAQ: BBLG) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets, today announced that it closed a public offering of 1,510,455 units of securities at an offering price of $5.25 per unit, for total gross proceeds of $7.9 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Each unit consists of one share of common stock and one warrant to

    10/15/2021BBLG
    WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering

    WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced the completion of an underwritten public offering of 1,510,455 units of Bone Biologics (NASDAQ: BBLG) at an offering price of $5.25 per unit for total gross proceeds of $7.9 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Each unit consists of one share of common stock and one warrant to purchase one share of common stock which wil

    10/13/2021BBLG
    WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisting to the NASDAQ Capital Market

    WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced the pricing of an underwritten public offering of 1,510,455 units of Bone Biologics (NASDAQ: BBLG) at an offering price of $5.25 per unit, for total gross proceeds of $7.9 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Each unit consists of one share of common stock and one warrant to purchase one share of common stock and will be

    10/13/2021BBLG
    Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split

    BURLINGTON, Mass., October 13, 2021--Bone Biologics Corp. (NASDAQ: BBLG) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets, today announced the pricing of its underwritten public offering of 1,510,455 units of securities at an offering price of $5.25 per unit, for total gross proceeds of $7.9 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Each unit consists of one share of common stock and